Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Merck Institute for Science Education | Researchclopedia

Back to institutions

Merck Institute for Science Education

Rahway, New Jerseynonprofit

346

Works

40,890

Citations

83

h-index

Top Research Topics

Cancer Immunotherapy and Biomarkers Analytical Chemistry and Chromatography Diverse Scientific and Economic Studies

Top Researchers

Paul G. Richardson Boston University

2,057 works131,367 citationsh-index: 170

Recent Research

Lenvatinib plus Pembrolizumab for Patients with Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results from the Phase II LEAP-005 Study

Mariano Ponz-Sarvise,Sun Young Rha,et al.

20260 citations

Molecular spectroscopy and chirality

Legal case studies and regulations

Computational Drug Discovery Methods

Lipoproteins and Cardiovascular Health

CAR-T cell therapy research

Respiratory and Cough-Related Research

Immunotherapy and Immune Responses

Pulmonary Hypertension Research and Treatments

Chemical Synthesis and Analysis

Thomas Meitinger TUM Klinikum

951 works130,111 citationsh-index: 168

Meletios Α. Dimopoulos Korea University

2,992 works128,440 citationsh-index: 159

Douglas A. Levine Merck & Co., Inc., Rahway, NJ, USA (United States)

829 works107,134 citationsh-index: 127

Lawrence A. Leiter St. Michael's Hospital

873 works90,094 citationsh-index: 138

Hong Liu Tianjin University of Technology

2,758 works89,635 citationsh-index: 135

Abstract PS2-06-17: Olaparib Use and gBRCA Testing among HER2-Negative Early-Stage Breast Cancer Patients in the United States Community Oncology Setting

K. Mishkin,M. Ru,et al.

20260 citations

A mitochondrial amidoxime-reducing component 1 (mARC1) A168T amino acid substitution does not confer protection from MASH and fibrosis in multiple mouse models of chronic liver disease

Sentibel Pandovski,Tiffany Yang,et al.

20250 citations

INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Danny Rischin,Aaron R. Hansen,et al.

20251 citations

KEYLYNK-009: Pembrolizumab plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer after Clinical Benefit from First-Line Pembrolizumab plus Chemotherapy

Hope S. Rugo,David W. Cescon,et al.

20250 citations

<i>MECP2-</i> Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer Therapy

Manish Neupane,Mukesh Kumar,et al.

20250 citations